Strategies in antibody therapy of cancer.
作者信息
Wawrzynczak E J, Davies A J
出版信息
Clin Exp Immunol. 1990 Nov;82(2):189-93. doi: 10.1111/j.1365-2249.1990.tb05425.x.
Abstract
摘要
相似文献
1
Strategies in antibody therapy of cancer.
Clin Exp Immunol. 1990 Nov;82(2):189-93. doi: 10.1111/j.1365-2249.1990.tb05425.x.
2
Monoclonal antibodies. Future potential in cancer chemotherapy.
Drugs. 1989 Nov;38(5):645-57. doi: 10.2165/00003495-198938050-00001.
3
Monoclonal antibodies and immunoconjugates for cancer treatment.
Cancer Chemother Biol Response Modif. 1987;9:409-31.
4
Monoclonal antibody immunoconjugates for cancer treatment.
Curr Opin Immunol. 1989 Jun;1(5):891-4. doi: 10.1016/0952-7915(89)90066-6.
5
Monoclonal antibodies and immunoconjugates for cancer treatment.
Cancer Chemother Biol Response Modif. 1988;10:397-415.
6
Monoclonal antibody 791T/36 immunoconjugates for cancer treatment.
Targeted Diagn Ther. 1989;2:53-72.
7
Serotherapy of cancer.
Semin Oncol. 1989 Jun;16(3):180-98.
8
A magic bullet for cancer--how near and how far?
N Engl J Med. 2001 Jul 26;345(4):283-4. doi: 10.1056/NEJM200107263450409.
9
[Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy].
Fortschr Med. 1994 Oct 20;112(29):399.
10
Antibody conjugates for the treatment of cancer.
Immunol Rev. 1992 Oct;129:57-80. doi: 10.1111/j.1600-065x.1992.tb01419.x.
引用本文的文献
1
Comparison of the cellular internalization of antibodies used either as immunotoxins or in ADEPT.
Cell Biophys. 1994;24-25:175-83. doi: 10.1007/BF02789228.
2
Systemic immunotoxin therapy of cancer: advances and prospects.
Br J Cancer. 1991 Oct;64(4):624-30. doi: 10.1038/bjc.1991.374.
本文引用的文献
1
Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells.
Cancer Res. 1981 Jun;41(6):2073-8.
2
Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.
Proc Natl Acad Sci U S A. 1981 Dec;78(12):7707-11. doi: 10.1073/pnas.78.12.7707.
3
Chemotherapy-increased antineoplastic effects of antibody-toxin conjugates.
Cancer Treat Rep. 1984 Apr;68(4):643-5.
4
Enhancement of macrophage invasion of tumors by administration of chemotactic factor-antitumor antibody conjugates.
Cell Immunol. 1983 Oct 1;81(1):169-74. doi: 10.1016/0008-8749(83)90222-8.
5
Immunomodulation: NK cells activated by interferon-conjugated monoclonal antibody against human osteosarcoma.
Eur J Cancer Clin Oncol. 1984 Jun;20(6):791-8. doi: 10.1016/0277-5379(84)90218-9.
6
Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates.
J Immunol. 1983 Mar;130(3):1473-7.
7
8
In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumors.
Haematol Blood Transfus. 1985;29:514-7. doi: 10.1007/978-3-642-70385-0_104.
9
Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8648-52. doi: 10.1073/pnas.82.24.8648.
10
Investigations of avidin and biotin for imaging applications.
J Nucl Med. 1987 Aug;28(8):1294-302.
Zotero 插件